COMMUNIQUÉS West-GlobeNewswire

Albireo to Report Year-End 2018 Financial Results and Host Conference Call and Webcast on March 7, 2019

27/02/2019 - 14:30

BOSTON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a [...]

Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results

27/02/2019 - 14:30

SOLANA BEACH, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company [...]

Hemispherx Biopharma Updates the Terms of Previously Announced Rights Offering and Announces Senior Management and Directors All Plan to Participate in the Offering

27/02/2019 - 14:30

OCALA, Fla., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical [...]

The State of Illinois Teams Up with Helix TCS to Take on the Opioid Epidemic -- CFN Media

27/02/2019 - 14:30

Seattle, WA, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]

Nanogen Launch Brings Revolutionary Cannabis and Hemp Nano Emulsions to Mainstream Food, Beverage, Health and Beauty Markets

27/02/2019 - 14:30

New nano-emulsion technology company takes oil from plants, makes it customizable and scalable for easy and cost-effective entry into existing supply chains OAKLAND, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Nanogen [...]

Helsinn Investment Fund: Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology

27/02/2019 - 14:15

Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology The Award recognizes Patient Entrepreneurs’ innovations for cancer and cancer supportive care using [...]

Notice to convene Annual General Meeting 2019 of GN Store Nord

27/02/2019 - 14:00

Please find enclosed notice of GN Store Nord A/S’ Annual General Meeting 2019, including the complete proposals for the agenda For further information, please contact: Investors and analysts Peter Justesen VP – Investor [...]

Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc.

27/02/2019 - 14:00

MIAMI, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that its wholly owned subsidiary PharmCo, LLC has met all three [...]

Milestone Scientific’s Director of Clinical Affairs Interviewed on Proactiveinvestors.com

27/02/2019 - 14:00

LIVINGSTON, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug instruments that provide painless and precise injections, today announced that Dr. [...]

Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to 1 Year

27/02/2019 - 14:00

Long Term Data on FMX103 Demonstrated a Generally Favorable Safety Profile; 81.6% of Patients Achieved Clear or Almost Clear Skin at 52 Weeks REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- [...]

Allogene Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results on March 8, 2019

27/02/2019 - 14:00

Conference Call and Webcast Scheduled for 5:30 AM PT/8:30 AM ET SOUTH SAN FRANCISCO, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company [...]

CEPI awards US$ 34M contract to CureVac to advance The RNA Printer™—a disruptive, transportable mRNA vaccine manufacturing platform that can rapidly combat multiple diseases

27/02/2019 - 13:30

OSLO, Norway, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG, a biopharmaceutical company pioneering the field of mRNA-based vaccines, have announced a [...]

Strongbridge Biopharma plc to Present at the Cowen and Company 39th Annual Healthcare Conference and the Oppenheimer 29th Annual Healthcare Conference

27/02/2019 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

Michigan: A Lucrative Cannabis Market with Tight Regulations -- CFN Media

27/02/2019 - 13:30

SEATTLE, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Sarepta Exercises Option to Acquire Myonexus Therapeutics

27/02/2019 - 13:30

-- Exercise Fee is $165 Million -- -- Sarepta to Acquire Myonexus’ Portfolio of Five Gene Therapy Candidates to Treat Distinct Forms of Limb-Girdle Muscular Dystrophy (LGMD) -- CAMBRIDGE, Mass., Feb. 27, 2019 (GLOBE [...]

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update

27/02/2019 - 13:30

NEW YORK, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update

27/02/2019 - 13:29

- On track for clinical data update from trials in multiple solid tumors at the Q1 2019 earnings update call in May - - Completed initial safety cohorts for ADP-A2M10 (MAGE-A10) in lung and triple tumor studies as well [...]

Resonant to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call on Thursday, March 14th at 1:30 p.m. Pacific Daylight Time

27/02/2019 - 13:05

GOLETA, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ:RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices [...]

Clearside Biomedical to Report 2018 Financial Results and Provide Corporate Update on Tuesday, March 12, 2019

27/02/2019 - 13:05

ALPHARETTA, Ga., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]